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Vitamin C synthesis in rat liver is enhanced by several
xenobiotics, including aminopyrine and chloretone. The
effect of these agents has been linked to induction of
enzymes potentially involved in the formation of glucu-
ronate, a precursor of vitamin C. Using isolated rat
hepatocytes as a model, we show that a series of agents
(aminopyrine, antipyrine, chloretone, clotrimazole, me-
tyrapone, proadifen, and barbital) induced in a few min-
utes an up to 15-fold increase in the formation of glucu-
ronate, which was best observed in the presence of
sorbinil, an inhibitor of glucuronate reductase. They
also caused an 2-fold decrease in the concentration of
UDP-glucuronate but little if any change in the concen-
tration of UDP-glucose. Depletion of UDP-glucuronate
with resorcinol or D-galactosamine markedly decreased
the formation of glucuronate both in the presence and in
the absence of aminopyrine, confirming the precursor-
product relationship between UDP-glucuronate and
free glucuronate. Most of the agents did not induce the
formation of detectable amounts of glucuronides, indi-
cating that the formation of glucuronate is not due to a
glucuronidation-deglucuronidation cycle. With the ex-
ception of barbital (which inhibits glucuronate reduc-
tase), all of the above mentioned agents also caused an
increase in the concentration of ascorbic acid. They had
little effect on glutathione concentration, and their ef-
fect on glucuronate and vitamin C formation was not
mimicked by glutathione-depleting agents such as dia-
mide and buthionine sulfoximine. It is concluded that
the stimulation of vitamin C synthesis exerted by some
xenobiotics is mediated through a rapid increase in the
conversion of UDP-glucuronate to glucuronate, which
does not apparently involve a glucuronidation-deglucu-
ronidation cycle.
Vitamin C synthesis, which takes place in the liver of most
mammalian species, starts with the formation of free glucu-
ronate from UDP-glucuronate, possibly via glucuronate 1-phos-
phate as an intermediate (Fig. 1). Reduction and lactonization,
probably in this order, lead to the formation of L-gulono-1,4-
lactone, which is oxidized to ascorbic acid by L-gulonolactone
oxidase, an enzyme associated to the endoplasmic reticulum
membrane (reviewed in Ref. 1). This enzyme is absent in sev-
eral species including humans and guinea pig, for which ascor-
bic acid is therefore a vitamin. L-gulonate can also be converted
in the liver to L-xylulose, through the successive action of
L-gulonate 3-dehydrogenase and 3-dehydro-L-gulonate decar-
boxylase. L-xylulose is then channeled to gluconeogenesis by
being converted to xylitol by NADPH-dependent L-xylulose re-
ductase and then to D-xylulose by D-xylulose reductase, a NAD-
dependent enzyme. Deficiency in the first of these two enzymes
results in a benign condition known as essential pentosuria
(reviewed in Ref. 2).
It has been known for several decades that the administra-
tion to rats of various drugs such as barbiturates, chloretone,
and aminopyrine markedly stimulates the formation and the
urinary excretion of vitamin C (3). Aminopyrine was also
shown to stimulate the excretion of L-xylulose in pentosuric
patients (4). Tracer studies in rats have shown that the forma-
tion of radiolabeled ascorbic acid is increased by chloretone
when glucose but not when D-glucuronolactone or L-gulonolac-
tone is used as a precursor (5), indicating that stimulation of
ascorbate production involves a step upstream of D-glucurono-
lactone. The mechanism of this effect is, however, still obscure.
One potential explanation, involving the formation of glucu-
ronides and their subsequent hydrolysis to free glucuronate,
appears unlikely in the case of barbital since this compound is
not significantly metabolized (3), but due to the diversity of
stimulating compounds, it is not clear whether this conclusion
applies to all of them. Induction of UDP-glucose dehydrogen-
ase, UDP-glucuronosyltransferase, and -glucuronidase has
been proposed to participate in the action of some agents (6–9).
Vitamin C synthesis has also been shown to be rapidly stimu-
lated in isolated mouse hepatocytes by agents that cause glu-
tathione depletion (menadione, diamide, buthionine sulfoxi-
mine), possibly via enhanced glycogenolysis (10). The purpose
of the present work was to test whether aminopyrine and other
compounds known to stimulate vitamin C and L-xylulose pro-
duction had a short term effect on the formation of glucuronate
in isolated rat hepatocytes, and if such an effect was found, to
determine at which step it took place and whether it was
related to glutathione depletion.
EXPERIMENTAL PROCEDURES
Materials—Clostridium histolyticum collagenase A and Escherichia
coli -glucuronidase were purchased from Roche Applied Science;
baker’s yeast glutathione reductase, aminopyrine, L-buthionine-(S,R)-
sulfoximine, clotrimazole, diamide, D-galactosamine, menadione, and
proadifen were from Sigma; chloretone and 2-vinylpyridine were pur-
chased from Acros; sodium barbital, dimethyl sulfoxide, and resorcinol
were from Merck; antipyrine was from Janssen Chimica; metyrapone
was from Aldrich. Sorbinil was a kind gift of Pfizer. All other reagents
were of analytical grade.
Preparation and Handling of Hepatocytes—Hepatocytes were iso-
lated from fed Wistar rats by a modification (11) of the method of Seglen
(12). The cells were resuspended in Krebs-Henseleit bicarbonate buffer
at a final concentration of 7–14 mg of protein/ml. Two-ml portions of
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this suspension were incubated at 37 °C in the presence of 5 mM glucose
in 20-ml vials equilibrated with a 95% O2, 5% CO2 gas phase. Amino-
pyrine or other compounds to be tested were added after a 20-min
incubation in the presence of Me2SO or sorbinil. Sorbinil, clotrimazole,
chloretone, and menadione were dissolved in Me2SO and added as
100-fold concentrated solutions; other compounds were dissolved in
water. For the measurement of glucuronate, -glucuronides, UDP-glu-
curonate, UDP-glucose, and ascorbic acid, the incubations were ar-
rested by mixing a portion of the cell suspension with 0.5 volume of cold
10% (w/v) perchloric acid. For the measurement of intracellular gluta-
thione, the cells were centrifuged through a silicone layer and quenched
in 10% (w/v) perchloric acid as described previously (13). For the meas-
urement of glucuronate, -glucuronides, UDP-glucuronate, and UDP-
glucose, the cell extracts were centrifuged, and the supernatants were
neutralized and stored at 20 °C until assay. For the measurement of
ascorbic acid and glutathione, the acidic supernatants of the cell ex-
tracts were stored at80 °C until assay. Protein was assayed (14) using
bovine serum albumin as a standard.
Measurement of Metabolites—Glucuronate was assayed spectropho-
tometrically using overexpressed and purified1 E. coli glucuronate
isomerase and mannonate dehydrogenase, which convert glucuronate
successively to fructuronate and mannonate, with concomitant oxida-
tion of NADH to NAD (15, 16). The two enzymes were added succes-
sively to a reaction mixture (1 ml) containing 50 mM Hepes, pH 7.1,
0.075 or 0.15 mM NADH, 0.01 mM EDTA, 0.1 mM MnCl2, and up to 200
l of neutralized perchloric acid extract. The decrease in A340 was
measured and used to calculate the concentration of glucuronate in the
sample. -Glucuronides were estimated through the difference between
the concentration of glucuronate before and after incubation with E. coli
-glucuronidase. For this, 200 l of neutralized perchloric acid extract
were incubated for 60 min at 37 °C in the presence of 50 mM Mes,2 pH
6.5, 100 g/ml bovine serum albumin, and 0.4 units/ml -glucuronidase
in a final volume of 225 l.
HPLC assays were used to determine the concentrations of nucleo-
tide sugars and ascorbic acid. UDP-glucuronate and UDP-glucose were
separated from each other and from other nucleotides by chromatogra-
phy of neutralized perchloric acid extracts (100 l) on a Partisphere Sax
column (4.6  125 mm; from Whatman) using a gradient of 0.01–0.5 M
NH4H2PO4 (pH 3.7) at a flow rate of 2 ml/min. A254 was measured, the
reference wavelength being 350 nm. Concentrations were calculated by
comparing the integrated peak surfaces with that of a titrated solution
of UMP. Ascorbic acid was determined by chromatographing non-neu-
tralized perchloric acid extracts (100 l) on an Alltima C18 column
(4.6  250 mm; from Alltech), which was then washed with 50 mM
KH2PO4 (pH 5.0) for 10 min at a flow rate of 1 ml/min. A240 was
measured to detect ascorbic acid, the reference wavelength being 350
nm. Ascorbic acid was eluted after 5 min, and the concentration was
calculated by comparing the integrated peak surface with the one of
standard ascorbic acid dissolved in 3.3% (w/v) perchloric acid. The
column was regenerated by washing for 4 min with a mixture contain-
ing 25 mM KH2PO4 (pH 5.0), 11% acetonitrile, and 22% methanol and by
washing for 4 min with the 50 mM KH2PO4 buffer. Results obtained
with this method were in excellent agreement with those obtained with
the dipyridyl reaction (17), except for samples containing aminopyrine.
The latter drug was indeed found to interfere in the colorimetric assay.
Total and oxidized glutathione were assayed by the glutathione
reductase assay (18). ATP was assayed as in Ref. 19.
RESULTS
Analysis of the Effect of Aminopyrine—The first question we
addressed was whether aminopyrine, one of the agents known
to stimulate vitamin C synthesis and pentose formation, would
provoke a detectable increase in the concentration of glucu-
ronate in isolated rat hepatocytes. As glucuronate is metabo-
lized to L-gulonate by glucuronate reductase, the incubations
were also carried out in the presence of sorbinil, an inhibitor of
this enzyme (20). As shown in Fig. 2, aminopyrine increased
the concentration of glucuronate in a dose-dependent manner,
and this effect was much larger in the presence of sorbinil,
which, by itself, also caused an increase in the concentration of
glucuronate. Similar experiments, in which perchloric acid ex-
tracts were prepared after separation of the cells from the
medium by centrifugation, indicated that 90% of the glucu-
ronate that had accumulated in the combined presence of ami-
nopyrine and sorbinil was intracellular (results not shown).
Since sorbinil had an almost maximal effect at 100 M, this
concentration was chosen in the following experiments.
The time course of the effect of 2 mM aminopyrine is shown in
Fig. 3. Following the addition of this agent, the glucuronate
concentration increased 4-fold in 5 min in the absence of
sorbinil and remained at this higher steady state value during
the rest of the experimental period (Fig. 3A). In the presence of
the glucuronate reductase inhibitor, the concentration of glu-
curonate increased to a larger extent and almost steadily dur-
ing the whole experimental period, although a little faster
during the first 5 min (0.40  0.03 mol/min/g of protein) than
1 C. L. Linster and E. Van Schaftingen, unpublished results.
2 The abbreviations used are: Mes, 4-morpholineethanesulfonic acid;
HPLC, high pressure liquid chromatography.
FIG. 1. Pathway of ascorbic acid
and L-xylulose formation. 1, UDP-glu-
cose dehydrogenase; 2, UDP-glucurono-
syltransferase; 3, -glucuronidase; 4, glu-
curonate reductase; 5, aldonolactonase;
6, L-gulono-1,4-lactone oxidase; 7, L-gu-
lonate 3-dehydrogenase; 8, 3-dehydro-L-
gulonate decarboxylase. The bracket indi-
cates the step stimulated by aminopyrine
and other agents, as shown in the present
report.
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at later times (0.24 0.02 mol/min/g of protein between 5 and
40 min).
As glucuronate is most likely formed from UDP-glucuronate,
we also measured the concentration of this nucleotide (Fig. 3B)
and of its precursor, UDP-glucose (Fig. 3C). Aminopyrine
caused a fall in the concentration of UDP-glucuronate, which
was unaffected by the presence of sorbinil, whereas it caused a
modest and transient increase in the concentration of UDP-
glucose, which was again not significantly affected by the pres-
ence of sorbinil.
To confirm that UDP-glucuronate was the precursor for the
formation of glucuronate, we checked whether resorcinol, a
readily glucuronidated phenol derivative (21), and D-galactos-
amine, which traps uridine nucleotides as UDP-galactosamine
and derivatives of it (22), would inhibit the formation of glucu-
ronate induced by aminopyrine in the presence of sorbinil. As
shown in Table I, both agents depleted UDP-glucuronate, and
in the case of galactosamine, also UDP-glucose. Both of them
decreased the basal concentration of glucuronate by a factor of
3 (resorcinol) and 4.5 (galactosamine) and almost abolished
the increase in glucuronate concentration induced by aminopy-
rine. Resorcinol caused the accumulation of a -glucuronide,
most likely resorcinylglucuronide, to a level that was 3-fold
higher than that of free glucuronate observed in the presence of
aminopyrine, consistent with the larger effect of resorcinol
rather than the effect of aminopyrine on the UDP-glucuronate
pool.
Effect of Other Compounds on the Formation of Free Glucu-
ronate—We also tested the effect of other compounds known to
stimulate the formation of ascorbic acid in vivo. As shown in
Fig. 4A, the formation of glucuronate was stimulated by chlor-
etone, antipyrine, and barbital in decreasing order of potency.
Stimulation was also observed with pentobarbital and phenyl-
butazone (both at 1 mM; not shown), a pyrazole derivative
similar to aminopyrine. No effect was observed with unsubsti-
tuted pyrazole (at 1 mM; not shown).
As aminopyrine is known to be metabolized by cytochrome
P450 (23), we checked whether inhibitors of cytochrome P450
could prevent the effect of the pyrazole derivative on glucu-
ronate formation. Quite surprisingly, the three inhibitors that
were tested, clotrimazole (24), proadifen, and metyrapone (25),
stimulated by themselves the formation of free glucuronate
(Fig. 4B), and their effect was not additive with that of ami-
nopyrine (not shown). In the case of clotrimazole and proadifen,
the highest concentration used (0.5 mM) had a lesser effect than
lower concentrations, presumably because of toxic effects. This
is consistent with the finding that, at a concentration of 0.5 mM,
both agents caused a marked decrease in the ATP concentra-
tion (down to 10% of the control level; not shown).
Taken together, these results indicate that the effect on
glucuronate formation is shared by compounds with quite var-
ied but rather hydrophobic structures. It should also be noted
that all agents that were investigated in Fig. 4 exerted a rapid
effect. This was indicated by the observation that the glucu-
ronate concentration, reached 10 min after the addition of a
maximally active concentration of the drugs, corresponded to
32–37% of the concentration reached after 40 min (results not
shown). This value is similar to the one obtained with ami-
nopyrine (37%, Fig. 3A).
The effects of some of the agents mentioned above were
further investigated in the experiment reported in Fig. 5. As for
aminopyrine, the effects of antipyrine, metyrapone, proadifen,
clotrimazole, and chloretone on free glucuronate were greatly
reinforced by sorbinil (Fig. 5A). This was, however, not the case
for barbital, presumably because the latter also inhibits glucu-
FIG. 2. Effect of aminopyrine and sorbinil on the concentra-
tion of glucuronate in isolated hepatocytes. Hepatocytes were
preincubated for 20 min in the presence of the indicated concentrations
of sorbinil (open circles, control without sorbinil; filled circles, 25 M
sorbinil; filled triangles, 100 M sorbinil; filled squares, 200 M sorbi-
nil). Aminopyrine was then added at the indicated concentrations, and
the incubations were arrested 40 min later. Glucuronate was assayed in
perchloric acid extracts prepared from the whole cell suspension. Re-
sults are means  S.E. for 4–5 experimental values.
FIG. 3. Time course of the effect of aminopyrine on the con-
centrations of glucuronate (A), UDP-glucuronate (B), and UDP-
glucose (C) in isolated hepatocytes. Hepatocytes were preincubated
for 20 min with (open and filled triangles) or without (open and filled
circles) 100 M sorbinil. Aminopyrine was then added at a final concen-
tration of 2 mM (filled symbols). Control incubations where aminopyrine
was omitted were also performed (open symbols). Perchloric acid ex-
tracts were prepared on the whole cell suspension at the indicated times
for the assay of metabolites. Results are means  S.E. for 4 experi-
ments. a and b indicate statistically significant difference (Student’s t
test; p  0.01) of the “aminopyrine” (filled circles) and “aminopyrine 
sorbinil” (filled triangles) conditions versus their appropriate control.
Con, control without sorbinil.
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ronate reductase (26). Similarly to aminopyrine, all agents
stimulating the formation of glucuronate caused a decrease in
the UDP-glucuronate pool (Fig. 5C). With the exception of
barbital, all of the agents also caused an increase in the forma-
tion of vitamin C, which was markedly (80%) inhibited by
sorbinil (Fig. 5D).
As glutathione depletion has been postulated to play a role in
the regulation of vitamin C synthesis (10), we also investigated
the effect of glutathione-depleting agents on the same param-
eters. Menadione, buthionine sulfoximine, and diamide caused
a significant decrease of intracellular glutathione (Fig. 5E) and
a significant increase in extracellular GSSG in the case of
menadione and diamide (not shown). Despite this, these agents
had little or no effect on the formation of free glucuronate or
ascorbic acid. By contrast, the agents that most stimulated
glucuronate and vitamin C formation had a much lesser or
insignificant effect on glutathione levels.
-Glucuronides were also measured in the experiment
shown in Fig. 5 as the difference between the concentration of
glucuronate before and after treatment with -glucuronidase
(Fig. 5B). As this is a difference assay, it is expected to be more
reliable for the conditions in which the free glucuronate con-
centration is low, i.e. where sorbinil has been omitted from the
incubation medium. However, there was a fair agreement be-
tween the values observed with and without the inhibitor of
glucuronate reductase, indicating the reliability of the assay
procedure. Among the agents that increased glucuronate for-
mation, only three (antipyrine, proadifen, and menadione) in-
duced the formation of -glucuronides, which reached concen-
trations (0.9–1.9 nmol/mg of protein) that were less than 1⁄20
of the concentration observed in the presence of resorcinol
(Table I).
DISCUSSION
The Conversion of UDP-glucuronate to Glucuronate as a Reg-
ulated Step in Vitamin C Synthesis—Previous studies using
radiolabeled galactose and glucose as precursors have indi-
cated that vitamin C is formed from a UDP-linked sugar,
presumably UDP-glucuronate (27). The precise mechanism by
which free glucuronate is formed, by way of glucuronate
1-phosphate (28, 29) or a glucuronidated intermediate (8, 30) or
even through a direct conversion of UDP-glucuronate to UDP
and glucuronate (Fig. 1), is presently unknown. Our study
provides two new pieces of evidence indicating the precursor-
product relationship between UDP-glucuronate and glucu-
ronate since (a) two agents (resorcinol and D-galactosamine)
that deplete UDP-glucuronate through quite distinct mecha-
nisms markedly reduce the formation of free glucuronate
whether in the absence or in the presence of aminopyrine; (b)
all agents that stimulate the formation of glucuronate cause an
50% decrease in the concentration of UDP-glucuronate.
In addition, our results indicate that aminopyrine and other
xenobiotics stimulate the formation of vitamin C and L-xylulose
by accelerating the conversion of UDP-glucuronate to glucu-
ronate. With the exception of barbital, which inhibits glucu-
ronate reductase (26), all agents stimulated the formation of
vitamin C (in the absence of sorbinil) in proportion with their
ability to stimulate the formation of glucuronate (in the pres-
ence of sorbinil). This is consistent with the concept that what
limits the formation of vitamin C is the availability of free
glucuronate. Vitamin C formation in the absence of sorbinil
amounted to 30% of the glucuronate that accumulated in the
presence of sorbinil, indicating that most of the glucuronate
formed from UDP-glucuronate is converted to L-xylulose. The
finding that sorbinil, which blocks the downstream conversion
TABLE I
Prevention of the stimulatory effect of aminopyrine on glucuronate formation by resorcinol and
D-galactosamine, two agents causing UDP-glucuronate depletion
Isolated hepatocytes were preincubated for 20 min with or without 1 mM resorcinol or 5 mM D-galactosamine, together with 100 M sorbinil.
Aminopyrine was then added at a final concentration of 2 mM, and the incubation was pursued for 40 min. Glucuronate, -glucuronides,
UDP-glucuronate, and UDP-glucose were assayed in perchloric acid extracts prepared on the whole cell suspension. Results are means  S.E. for
4 experiments.
Condition Glucuronate -Glucuronides UDP-glucuronate UDP-glucose
nmol/mg of protein nmol/mg of protein nmol/mg of protein nmol/mg of protein
Control 1.81  0.50 0.07  0.07 2.32  0.21 1.49  0.11
2 mM aminopyrine 15.38  1.85a 0.19  0.16 1.06  0.15a 1.49  0.11
1 mM resorcinol 0.65  0.11 43.34  4.12a 0.08  0.08a 0.99  0.15a
2 mM aminopyrine  1 mM resorcinol 1.20  0.24b 44.38  3.20a,b 0.04  0.04a,b 1.04  0.10a,b
5 mM D-galactosamine 0.40  0.12a 0.20  0.03 0.07  0.04a 0.04  0.02a
2 mM aminopyrine  5 mM D-galactosamine 1.01  0.43b 0.10  0.06 0.03  0.03a,b 0.03  0.02a,b
a Significantly different from control by Student’s t test (p  0.05).
b Significantly different from 2 mM aminopyrine.
FIG. 4. Dose dependence of the effect of stimulators of vitamin
C formation (A) and of inhibitors of cytochrome P450 (B) on the
formation of free glucuronate in isolated hepatocytes incubated
with sorbinil. Hepatocytes were preincubated for 20 min with 100 M
sorbinil before the addition of the indicated agents (filled diamonds,
chloretone; filled squares, antipyrine; filled triangles, barbital; filled
circles, metyrapone; open squares, proadifen; open circles, clotrimazole)
at the indicated concentrations. The incubations were arrested 40 min
later, and glucuronate was measured in perchloric acid extracts pre-
pared on the whole cell suspension. Results are means  S.E. for 3–4
experimental values.
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of glucuronate to L-gulonate, did not modify the decrease in
UDP-glucuronate induced by aminopyrine and other xenobiot-
ics indicates that free glucuronate, as well as downstream
metabolites, exerts no or little effect on glucuronate formation.
The finding that glucuronate remains essentially intracellu-
lar, together with the fact that glucuronate added to the extra-
cellular medium is not taken up by hepatocytes,3 indicates that
the hepatocyte plasma membrane does not contain a trans-
porter for glucuronate. This sugar derivative behaves therefore
essentially as an intracellular metabolite, in a similar manner
as intermediates of other intracellular pathways such as gly-
colysis and the pentose phosphate pathway. Absence of glucu-
ronate transport in the hepatocyte plasma membrane may
explain previous results showing that intraperitoneally admin-
istered glucuronate, at variance with 3,6-glucuronolactone, is
not converted to vitamin C in vivo (5).
Finally, except for the recent study on the effect of glutathi-
one-depleting agents (10), all previous studies had been per-
formed in vivo, and it was therefore not clear whether other
organs, hormones, or circulating factors were involved in the
effect of aminopyrine and other drugs. The finding that the
stimulation of glucuronate and vitamin C formation can take
place in isolated hepatocytes indicates that it does not require
short term hormonal influences or organ-to-organ transfer of
metabolites or modified xenobiotics (also, see below).
Involvement of a Short Term Effect—Most of the studies
previously investigating the effect of aminopyrine and other
xenobiotics on glucuronate and vitamin C formation put the
emphasis on the ability of these compounds to induce the
synthesis of enzymes such as UDP-glucose dehydrogenase,
UDP-glucuronosyltransferase, and -glucuronidase that par-
ticipate, or may participate, in the formation of glucuronate
(6–9). The present study shows that the stimulation caused by
these agents is already maximal at the shortest investigated
times (5 or 10 min). In the presence of sorbinil, which blocks
further conversion of glucuronate, stimulation of the formation
of this metabolite reaches up to 15-fold. The amplitude of this
effect indicates that regulation of free glucuronate and vitamin
C formation may largely be a short term effect.
A previous study has shown that glutathione-depleting
agents stimulate the formation of vitamin C in isolated mouse
hepatocytes (10). Of the glutathione-depleting agents that we
tested (menadione, buthionine sulfoximine, and diamide), the
only one that stimulated glucuronate formation was menadi-
one, and it had a much lesser effect than agents such as
aminopyrine, metyrapone, and proadifen that did not signifi-
cantly affect GSH concentration. In contrast to Braun et al. (10),
we did not find a stimulatory effect of the glutathione-depleting
agents on vitamin C formation. We have no clear explanation for
this discrepancy. The use of different vitamin C assays (by HPLC
in our case and by a colorimetric assay in the case of Braun et al.
(10)) provides no explanation since we found identical results
with the colorimetric assay as with the HPLC assay, except for an
interference of aminopyrine in the colorimetric assay (not
shown). Other potential explanations might be linked to a species
difference (rat versus mouse) or to dietary influences.
3 C. L. Linster, unpublished results.
essentially (	94%) present in its reduced form under all conditions. In the
case of vitamin C, the results are presented as the difference between the
concentration found in the indicated condition and the concentration
found at the same time in the presence of sorbinil only. Under the latter
condition, the vitamin C content was 7.61  1.60 nmol/mg of protein.
Results are means S.E. for 3 experiments. *, significantly different from
the appropriate control by Student’s t test (p  0.05). intracell, intracel-
lular; L-BOS, L-buthionine-(S,R)-sulfoximine.
FIG. 5. Effect of various compounds on the concentrations of
glucuronate (A), -glucuronides (B), UDP-glucuronate (C), and
glutathione (E) and on the formation of vitamin C (D). Hepato-
cytes were preincubated for 20 min with (black bars) or without (gray
bars) 100 M sorbinil before the addition of the indicated agents at the
indicated concentrations. The incubations were arrested 20 min later
for the assay of glutathione and 40 min later for the assay of glucu-
ronate, -glucuronides, UDP-glucuronate, and vitamin C. Glucuronate,
-glucuronides, UDP-glucuronate, and vitamin C were measured in
perchloric acid extracts prepared from the total cell suspension,
whereas total glutathione (GSH  GSSG) was assayed in perchloric
acid extracts prepared by centrifugation of the cells through a silicone
layer, thus representing total intracellular glutathione. The latter was
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The effect of glutathione depletion has been linked to glyco-
gen degradation (10). In this case, the increase in glucuronate
formation would be mediated through a push effect, i.e.
through an increase in the concentrations of glucose 1-phos-
phate, UDP-glucose, and UDP-glucuronate. However, all
agents that stimulated the formation of free glucuronate
caused a decrease rather than an increase in the concentration
of UDP-glucuronate (Figs. 3B and 5C) and barely affected the
UDP-glucose concentration (Fig. 3C and data not shown). Fur-
thermore, glucagon and dibutyrylcyclic AMP failed to affect
glucuronate formation in isolated rat hepatocytes.3 We have
therefore no reason to believe that the effect of agents that
stimulated glucuronate formation in the present study was
linked to enhanced glycogen degradation or to glutathione
depletion.
As mentioned in the Introduction, it has been proposed that
free glucuronate is formed by hydrolysis of glucuronidated me-
tabolites arising from the stimulating drugs. In vivo, this hy-
drolysis could potentially take place in the intestine following
secretion of glucuronidated metabolites in the bile. This possi-
bility can be excluded in the isolated hepatocyte model used in
the present study. Furthermore, two pieces of evidence argue
against intracellular hydrolysis of glucuronides taking place
inside hepatocytes. The first one is that little if any glucu-
ronidated metabolite was formed with the agents that stimu-
lated the formation of free glucuronate, whereas an agent such
as resorcinol, which leads to the accumulation of an elevated
concentration of its glucuronidated metabolite, did not cause
any formation of free glucuronate. The second is that, if a
glucuronidated precursor had to accumulate before glucu-
ronate would form, free glucuronate would appear with a lag
kinetic, whereas the opposite was observed. Actually, the for-
mation of glucuronate slowed down after an initial rapid pe-
riod, most likely because of the decrease in the UDP-glucu-
ronate concentration.
Nonetheless, a good argument in favor of a role of UDP-
glucuronosyltransferases is the finding of Horio et al. (8) that
the 3-methylcholanthrene-induced increase in the urinary ex-
cretion of ascorbic acid observed in vivo is reduced in heterozy-
gous Gunn rats and abolished in homozygous Gunn rats. These
rats have a mutation in the gene encoding the UDP-glucurono-
syltransferase that is induced by 3-methylcholanthrene (31),
explaining the lack of effect of this chemical on the transferase
activity. Combined with our own results, which point to a short
term effect and to the absence of a glucuronidated intermedi-
ate, these data raise the possibility that non-glucuronidable
xenobiotics may combine with UDP-glucuronosyltransferase(s)
and induce a UDP-glucuronate hydrolase activity, either by
acting as pseudosubstrates or through an allosteric effect. Ev-
idence for a UDP-glucuronidase activity of a purified UDP-
glucuronosyltransferase has been reported previously (32). It
has indeed been shown that the addition of compounds (phen-
ylethyl ether, phenylphenyl ether, p-nitrophenylphenyl ether)
that bind to the aglycone site of GT2P, a UDP-glucuronosyl-
transferase purified from pig liver, but are not substrates of
this enzyme, led to the formation of free glucuronate at a rate
representing up to 0.03% of the rate of glucuronidation of
p-nitrophenol. This formation of free glucuronate is stimulated
by lysophosphatidylcholine, as is the glucuronidation reaction
catalyzed by the same enzyme. Because of the multiplicity of
UDP-glucuronosyltransferases, such a mechanism could ac-
count for the wide diversity of the compounds that stimulate
free glucuronate formation, as well as for their hydrophobicity,
a characteristic of the substrates, and presumably also of the
pseudosubstrates, of this group of enzymes (33). Although the
rate of UDP-glucuronate hydrolysis observed with GT2P may
appear quite low, it is likely that other agents acting on other
UDP-glucuronosyltransferases induce higher rates of -glucu-
ronidase activity. Preliminary data obtained on rat liver ex-
tracts or microsomes indicate, however, that aminopyrine,
chloretone, and metyrapone barely (by less than 20%) affect the
formation of glucuronate from UDP-glucuronate, which sug-
gests that the regulation of glucuronate formation from UDP-
glucuronate may be quite complex and may involve factors that
are lost after cell homogenization.
Further work is obviously needed to determine the identity
of the enzyme(s) responsible for the formation of glucuronate.
Its (their) ability to respond rapidly to xenobiotics is a property
that will certainly be helpful for its (their) identification as well
as for the unraveling of the factors that control its (their)
activity under physiological conditions.
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